Literature DB >> 25062988

Non-motor symptoms in Chinese Parkinson's disease patients with and without LRRK2 G2385R and R1628P variants.

Da-Wei Li1, Zhuqin Gu, Chaodong Wang, Jinghong Ma, Bei-Sha Tang, Sheng-Di Chen, Piu Chan.   

Abstract

Non-motor symptoms (NMS) are common among patients with Parkinson's disease (PD). However, reports on NMS in Chinese PD population are scarce. Little is known about NMS in patients with Asian specific leucine-rich repeat kinase 2 (LRRK2) variants in G2385R and R1628P. This study aimed to elucidate the clinical characteristics of NMS in Chinese PD patients and to ascertain if there were differences in NMS between PD patients with and without LRRK2 variants. A multicenter, observational study was conducted with 1,225 sporadic PD (sPD) patients recruited from a PD cohort of the Chinese National Consortium on neurodegenerative diseases, 163 participants had the LRRK2 variants. The Non-motor Symptom Questionnaire (NMSQ) was used to screen for the presence of NMS. This study found the majority of sPD patients (97.6 %) had at least one NMS. A mean of 8.72 NMS (SD = 5.43) was reported per patient. Forgetfulness, constipation and daytime sleepiness were found to be the most frequent NMS. Moreover, the number of NMS was positively correlated with the age, disease duration, Hoehn & Yahr stage and the motor scores of the unified Parkinson's disease rating scale. Although no discrepancy was found in the number of NMS between sPD patients with and without LRRK2 variants, nocturia was less common in LRRK2 variants carriers than in non-carriers (P = 0.045). NMS appear to be prevalent in Chinese sPD population. There are no differences in the NMS phenotype between LRRK2 and no LRRK2 patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25062988     DOI: 10.1007/s00702-014-1281-4

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  34 in total

Review 1.  Epidemiology of Parkinson's disease and akinetic syndromes.

Authors:  C M Tanner; D A Aston
Journal:  Curr Opin Neurol       Date:  2000-08       Impact factor: 5.710

2.  The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire.

Authors:  K Ray Chaudhuri; Cristina Prieto-Jurcynska; Yogini Naidu; Tanya Mitra; Belen Frades-Payo; Susanne Tluk; Anne Ruessmann; Per Odin; Graeme Macphee; Fabrizio Stocchi; William Ondo; Kapil Sethi; Anthony H V Schapira; Juan Carlos Martinez Castrillo; Pablo Martinez-Martin
Journal:  Mov Disord       Date:  2010-04-30       Impact factor: 10.338

3.  Economic burden of Parkinson's disease in a developing country: a retrospective cost analysis in Shanghai, China.

Authors:  Gang Wang; Qi Cheng; Rui Zheng; Yu-Yan Tan; Xiao-Kang Sun; Hai-Yan Zhou; Xiao-Lai Ye; Ying Wang; Zeng Wang; Bo-Min Sun; Sheng-Di Chen
Journal:  Mov Disord       Date:  2006-09       Impact factor: 10.338

4.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

5.  Validation of the Chinese non-motor symptoms scale for Parkinson's disease: results from a Chinese pilot study.

Authors:  Gang Wang; Zhen Hong; Qi Cheng; Qin Xiao; Ying Wang; Jing Zhang; Jian-fang Ma; Xi-jin Wang; Hai-yan Zhou; Sheng-di Chen
Journal:  Clin Neurol Neurosurg       Date:  2009-03-17       Impact factor: 1.876

Review 6.  A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management--a systematic review and meta-analysis.

Authors:  Jean-Nicolas Cornu; Paul Abrams; Christopher R Chapple; Roger R Dmochowski; Gary E Lemack; Martin C Michel; Andrea Tubaro; Stephan Madersbacher
Journal:  Eur Urol       Date:  2012-07-20       Impact factor: 20.096

7.  Pain perception in patients with Parkinson's disease.

Authors:  Tomasz Tykocki; Anna Kornakiewicz; Tomasz Mandat; Paweł Nauman
Journal:  J Clin Neurosci       Date:  2013-02-26       Impact factor: 1.961

8.  The LRRK2 Arg1628Pro variant is a risk factor for Parkinson's disease in the Chinese population.

Authors:  Chin-Song Lu; Yah-Huei Wu-Chou; Marina van Doeselaar; Erik J Simons; Hsiu-Chen Chang; Guido J Breedveld; Alessio Di Fonzo; Rou-Shayn Chen; Yi-Hsin Weng; Szu-Chia Lai; Ben A Oostra; Vincenzo Bonifati
Journal:  Neurogenetics       Date:  2008-08-21       Impact factor: 2.660

9.  Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers.

Authors:  C Marras; B Schüle; B Schuele; R P Munhoz; E Rogaeva; J W Langston; M Kasten; C Meaney; C Klein; P M Wadia; S-Y Lim; R S-I Chuang; C Zadikof; T Steeves; K M Prakash; R M A de Bie; G Adeli; T Thomsen; K K Johansen; H A Teive; A Asante; W Reginold; A E Lang
Journal:  Neurology       Date:  2011-07-13       Impact factor: 9.910

10.  123I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations.

Authors:  Francesc Valldeoriola; Carles Gaig; Africa Muxí; Ignacio Navales; Pilar Paredes; Francisco Lomeña; Andres De la Cerda; Mariateresa Buongiorno; Mario Ezquerra; Pilar Santacruz; Maria Jose Martí; Eduardo Tolosa
Journal:  J Neurol       Date:  2011-01-08       Impact factor: 4.849

View more
  8 in total

1.  Olfactory Dysfunction in Parkinson's Disease Patients with the LRRK2 G2385R Variant.

Authors:  Ming Cao; Zhu-Qin Gu; Yuan Li; Hui Zhang; Xiao-Juan Dan; Shan-Shan Cen; Da-Wei Li; Piu Chan
Journal:  Neurosci Bull       Date:  2016-10-03       Impact factor: 5.203

2.  LRRK2 G2019S Mutation: Prevalence and Clinical Features in Moroccans with Parkinson's Disease.

Authors:  Ahmed Bouhouche; Houyam Tibar; Rafiqua Ben El Haj; Khalil El Bayad; Rachid Razine; Sanaa Tazrout; Asmae Skalli; Naima Bouslam; Loubna Elouardi; Ali Benomar; Mohammed Yahyaoui; Wafa Regragui
Journal:  Parkinsons Dis       Date:  2017-03-30

3.  The Association between LRRK2 G2385R and Phenotype of Parkinson's Disease in Asian Population: A Meta-Analysis of Comparative Studies.

Authors:  Wei Di; Zhiyong Zeng; Jingyan Li; Xiaoling Liu; Minzhi Bo; Hua Lv
Journal:  Parkinsons Dis       Date:  2018-07-10

4.  Sex effects on clinical features in LRRK2 G2385R carriers and non-carriers in Parkinson's disease.

Authors:  Shi-Shuang Cui; Rao Fu; Juan-Juan Du; Yi-Qi Lin; Pei Huang; Chao Gao; Hai-Yan Zhou; Sheng-Di Chen
Journal:  BMC Neurosci       Date:  2021-03-26       Impact factor: 3.288

Review 5.  Genetic heterogeneity on sleep disorders in Parkinson's disease: a systematic review and meta-analysis.

Authors:  Jingxuan Huang; Yangfan Cheng; Chunyu Li; Huifang Shang
Journal:  Transl Neurodegener       Date:  2022-04-08       Impact factor: 8.014

6.  Self-Reported Visual Complaints in People with Parkinson's Disease: A Systematic Review.

Authors:  Iris van der Lijn; Gera A de Haan; Famke Huizinga; Fleur E van der Feen; A Wijnand F Rutgers; Catherina Stellingwerf; Teus van Laar; Joost Heutink
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

7.  Effect of a Leucine-rich Repeat Kinase 2 Variant on Motor and Non-motor Symptoms in Chinese Parkinson's Disease Patients.

Authors:  Qian Sun; Tian Wang; Tian-Fang Jiang; Pei Huang; Dun-Hui Li; Ying Wang; Qin Xiao; Jun Liu; Sheng-Di Chen
Journal:  Aging Dis       Date:  2016-05-27       Impact factor: 6.745

8.  The impact of nonmotor symptoms on quality of life in patients with Parkinson's disease in Taiwan.

Authors:  Weng-Ming Liu; Ru-Jen Lin; Rwei-Ling Yu; Chun-Hwei Tai; Chin-Hsien Lin; Ruey-Meei Wu
Journal:  Neuropsychiatr Dis Treat       Date:  2015-11-11       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.